Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis – experiences from a single center
Farkas, Klaudia, Rutka, Mariann, Ferenci, Tamás, Nagy, Ferenc, Bálint, Anita, Bor, Renáta, Milassin, Ágnes, Fábián, Anna, Szántó, Kata, Végh, Zsuzsanna, Kürti, Zsuzsanna, Lakatos, Péter L., Szepes, ZoLangue:
english
Journal:
Expert Opinion on Biological Therapy
DOI:
10.1080/14712598.2017.1363885
Date:
August, 2017
Fichier:
PDF, 2.01 MB
english, 2017